TX
Texas Senate Bill SB2308

Texas 2025 - 89th Regular

Texas Senate Bill SB2308

Filed
3/11/25  
Out of Senate Committee
4/28/25  
Voted on by Senate
4/30/25  
Out of House Committee
5/12/25  
Bill Becomes Law
 

Caption

Relating to the establishment of a consortium to conduct United States Food and Drug Administration's drug development clinical trials with ibogaine to secure the administration's approval of the medication's use for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy and to the administration of that treatment.

Latest SB2308 Activity

Companion Bills

TX HB3717

Similar Relating to the establishment of a grant program to fund the United States Food and Drug Administration's drug development trials with ibogaine for the purpose of securing the administration's approval as a medication for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy.

Similar Bills

TX HR1495

Suspending limitations on conference committee jurisdiction, S.B. No. 2308.

TX SR703

Suspending limitations on conference committee jurisdiction, S.B. No. 2308.

TX SB264

Relating to the establishment of the Texas Research Consortium to Cure Infectious Diseases (TRANSCEND); authorizing the issuance of bonds.

TX SB601

Relating to the creation and activities of the Texas Produced Water Consortium.

DE HB169

An Act To Amend Title 16 Of The Delaware Code Relating To The Behavioral Health Consortium And The Prescription Opioid Distribution Commission.

TX SB377

Relating to the Texas Achieving a Better Life Experience (ABLE) Program.

TX SB10

Relating to the creation of the Texas Mental Health Care Consortium.

TX HB3447

Relating to the establishment and administration of the Texas Space Commission and the Texas Aerospace Research and Space Economy Consortium.